ARTICLE | Clinical News
Flublok: Phase III data
March 18, 2013 7:00 AM UTC
A double-blind Phase III trial in 1,060 elderly volunteers showed that ASP7374 was non-inferior to an approved egg-derived trivalent inactivated vaccine in terms of immunogenicity. Details were not di...